ERRATUM|
November 24, 2022
Collins PJ, Fox CP, George L, et al. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 2021;137(2):203-215.
Blood (2022) 140 (21): 2306.
Connected Content
This is a related article to:
Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells
Citation
Collins PJ, Fox CP, George L, et al. Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood. 2021;137(2):203-215.. Blood 2022; 140 (21): 2306. doi: https://doi.org/10.1182/blood.2021013012
Download citation file: